The first month of 2022 was not kind to stock values across the board, as the Omicron variant swept across the country. And while home health and post-acute providers didn’t emerge unscathed, they fared considerably better than the S&P according to the latest Home Health (HHI) and Post-Acute Care (PAI) indices from national mergers and acquisitions advisory firm Stoneridge Partners.

“Home health and post-acute providers had a rough go of it in 2021, but stocks started to gain momentum at the end of the year – until Omicron hit,” said Stoneridge Managing Partner Brian Bruenderman. “The new variant really took a toll on providers, with record numbers of staff out of work and in quarantine.”

Yet both the HHI and PAI outperformed the market as a whole, dropping about 5% and 6%, respectively, in January — the S&P dropped close to 15% over that same time period.

Post-Acute Care Index

The number of Encompass Health Corporation (NYSE: EHC) employees with COVID-19 hit an all-time record in January, forcing the provider to turn away even more admissions after already losing 1,700 in the fourth quarter of 2021. Still, Encompass was down just 5% month-over-month. And Barb Jacobsmeyer, who helms Encompass Health’s home health and hospice segment — soon to be Enhabit Home Health & Hospice — says she is very optimistic about the company’s ability to start reining in those lost admissions in February and beyond.

Post-acute care companies are still bullish about the future, particularly as the Omicron wave has started to subside. Moving forward, providers indicate they will focus more on retention of current staff and recruitment of new staff, as opposed to plugging holes for quarantining workers.

Elsewhere in the PAI, Brookdale Senior Living Inc. (NYSE: BKD) performed admirably in January, up by 3%. Meanwhile, The Pennant Group, Inc. struggled, down 40% in January as compared to December.

Home Health Index

In January, Amedisys, Inc. (Nasdaq: AMED) and LHC Group, Inc. (Nasdaq: LHCG) were down by 9% and 13%, respectively.

Amedisys continued on its growth trajectory, announcing an agreement to acquire Evolution Health, a Dallas-based provider of home health, hospice and infusion therapy services. According to analysts, Amedisys paid anywhere from $70 to $75 million for Evolution, suggesting the company was reigniting its home health M&A engine as January came to a close.

LHC Group echoed its peers’ concerns about staffing issues in January, and leaders say mitigating those issues remains a priority.

“Labor pressures and shortages have been so much a focus for the industry, especially over the back half of 2021,” LHC Group President and COO Josh Proffitt told Home Health Care News in January. “I would say, in connection with that, improvements in recruiting and retention will be a main force moving forward. Providers are focused on mitigating those pressures.”

Even with all the difficulties home health providers have faced throughout the pandemic, their year-over-year performance has remained strong; compared to 12 months ago, the HHI is still up more than 21%.

Quote of the Month

“If we can deliver the right behavioral health response at the right time, then patients and their families don’t have to wait for a bad situation to get worse before receiving attention.” – Alyna T. Chien, MD, MS, the research director for the division of general pediatrics at Boston Children’s Hospital and assistant professor of pediatrics at Harvard Medical School.

Read the Full Article Here: Most practices struggle to support kids with behavioral health needs

Articles Featuring Stoneridge

View our quarterly M&A webinars on current valuation trends, deal flow, and pertinent regulatory changes in home health, home care, hospice, ID/DD and behavioral health industries. Visit the Speaker Series Webinar Library on our website.

See It To Believe It!

The Stoneridge Partners Home Health Index (HH Index) is updated monthly and measures the performance of these two publicly traded home health companies, all listed on the NASDAQ:

  • LHC Group (LHCG)
  • Amedisys (AMED)

Here are the results of the stock prices for the past two years:

Company 1/31/22 1 mos change YTD change 1/31/21 1/31/20
Amedisys 135.04 -16.58% -16.58% 289.07 176.49
LHC Group 124.81 -9.05% -9.05% 199.11 145.75
HH Index* 129.93 -13.13% -13.13% 244.09 161.12
S&P 4522.67 -5.11% -5.11% 3731.17 3225.52
Addus 79.74 -14.73% -14.73% 112.67 94.34

Although we track the performance of Addus, they are not included in our HH Index because very little of their revenue comes from Medicare.

Enterprise Value (EV)

EV (in M) 2022 2021 2020
Amedisys 4490 10370 6200
LHC Group 4050 6760 5000
HH Index Total 8540 17130 11200
Addus 1280 1950 1470


Enterprise Value (EV), aka Selling Price, as Percent of Revenue

Company 2022 2021 2020
Amedisys 204% 513% 328%
LHC Group 187% 328% 243%
HH Index Average* 196% 421% 286%
Addus 153% 256% 222%

The Stoneridge Partners Post-Acute Care Index is updated monthly and measures the performance of these six publicly traded post-acute care companies, all listed on the NASDAQ:

  • LHC Group (LHCG)
  • Amedisys (AMED)
  • Addus (ADUS)
  • The Pennant Group, Inc. (PNTG)
  • Encompass Health (EHC)
  • Brookdale Senior Living Inc. (BKD)

This graph displays Post-Acute Care Index performance starting late 2019.

The above calculations are based on selling price being defined as Enterprise Value (EV), with data provided by Capital IQ. Enterprise value is defined as market cap plus debt, minority interest and preferred shares, minus total cash and cash equivalents. EBITDA is calculated using methodology which may differ from that used by a company for its reporting. (Home Health Index February 2022 | Stoneridge Partners)

Exclusively Listed For Sale By Stoneridge Partners


Do you know of any acquisitions that have taken place? We are interested in your comments. Contact us at Stoneridge Partners.

Well-established and profitable franchisee.  Revenue of $4.9M.  Medicaid and private pay.

 Home Care /  Southwest / New

Private-duty home care.  Projected 2022 revenue of $2M.  Strong bottom line.

 Home Care /  Virginia

Hospice.  135+ADC.  Accredited.  No CAP or regulatory issues.

 Hospice /  Arizona

Clinical trial pharmacy with $30M in revenue.  Long operating history.  Highly profitable with nice growth trends.

 Pharmacy /  Northeast

ABA in-home autism therapy for children.  $2.4M in revenue.  Strong growth and bottom line.

 Other /  California

Opportunity to acquire a Medicare-certified home health agency. JCAHO-accredited.  Zero deficiencies.  Region 9.

 Home Health /  Florida

Opportunity to acquire a Medicare-certified home health agency.  JACHO-accredited.  Zero deficiencies.  Minimal census.

 Home Health /  Pennsylvania

Opportunity to acquire a Medicare-certified home health agency.  Zero deficiencies.  Minimal census.

 Home Health /  Kansas

Rare southern hospice/home health CON opportunity.  $3.5M in revenue, 60+ hospice ADC.  Strong staff recruiting and retention.

 Home Health /  South

Medicaid/private pay, Medicare-certified.  $3 million in revenue.  CHAP-accredited.

 Massachusetts

$3M pediatric agency in Chicago.  Long-term management in place.

 Other /  Illinois

Private duty home care franchise.  Dual-licensed home health/home care companion agency.  $1M+ in revenue. Attractive market with excellent growth potential.

 Home Care /  Florida

Large home care franchisee.  $5M in revenue.  100% private pay.  Consistent growth trajectory.

 Home Care /  Virginia

$1.5 million home health company.  Medicare/Medicaid-certified.  Primarily skilled services.  80+% HMO.  15+% Medicare.

 Home Health /  Massachusetts

4-star home health agency.  $2.5 million revenue.  Experienced management team.  Strong financials with outstanding local reputation.  Huge growth opportunities.

 Home Health /  Michigan

$1.5 million revenue chiropractic/physical therapy business.  High profit margin/low operating costs.  Diverse referral sources.

 Other /  Maryland

Medicare/Medicaid-certified home health organization.  $8+ million in annual revenue.  Diverse payor sources.  Multiple locations.

 Home Health /  Ohio

Approx. $700,000 non-skilled home health company.  Located in Florida's panhandle.  Accredited.  1/4 Private, 1/4 VA, 1/2 Medicaid waiver.  All employees are W-2.

 Home Health /  Florida

$3.3 million in revenue.  Autism center providing ABA, OT, PT and ST.  In-clinic and in-home services.

 Other /  Michigan

Non-skilled licensed home care organization.  Approx. $2 million in annual revenue.  Strong management team in place.  Southern California.

 Home Care /  California

Joint Commission-accredited psychiatric treatment center.  Residential, PHP, IOP, OP and home health services.  National referral base; reputation for excellence, innovation.  $3M EBITDA on $7M revenue...

 Behavioral Health /  Midwest

Central Ohio-based home health company with private pay.  $2.3 million in revenue.  13.5% EBITDA.  Strong growth trends, full staff in place.

 Home Health /  Ohio

Large home care franchisee.  $6.5 million in revenue.  Private duty.  Attractive market with great growth potential.

 Home Care /  Florida

Non-medical home care franchisor.  Platform opportunity with national footprint.  Systemwide revenues more than $12 million.  Franchise locations in 16 states.

 Home Care /  Texas

$2+ million private pay.  Profitable with great reputation.

 Home Health /  Pennsylvania

Profitable hospice agency with $600,000 in revenue.  Ready to grow with full complement of staff in place.

 Hospice /  Pennsylvania

CHAP-accredited private duty business.  $2.8 million projected 2021 revenue.  Workers' compensation primary source of revenue.  Regions 9, 10 and 11.

 Home Health /  Florida

Very rare opportunity in a CON state.  Located in Davidson County in Nashville, TN.  2020 revenue in excess of $650,000.

 Home Health /  Tennessee

Non-skilled home care company.  $10+ million in annual revenue.  Predominantly Medicaid.  Highly profitable.  Accredited.  Strong management team in place.

 Home Care /  Northeast

$1 million Medicare home health agency in northwest Minnesota.  Well-established.  Diverse referral sources.  Long history of excellent care.

 Home Health /  Minnesota

$4.9 million Medicare home health agency located in Phoenix, Arizona.  Showing strong year over year revenue growth since 2018.  Diverse referral sources, well run with...

 Home Health /  Arizona

Hospice with $3.5 million in annual revenue. Accredited. No cap or regulatory issues.

 Hospice /  Texas

$2.5 million New Mexico home health agency. 87% Medicare. Long history in the community and existing staff in place.

 Home Health /  New Mexico

Home Health Index February 2022 | Stoneridge Partners

From Brian Bruenderman, Publisher of “Home Health Index.” Brian can be reached at [email protected] or (239) 561-0826, and toll-free at 800-218-3944. Previous editions of this monthly newsletter can be searched for at the bottom of the home page of the Home Health Index. Links to Google Finance: Amedisys | LHC Group